Objective and design: The use of proton pump inhibitors in acid-related diseases such as peptic ulcer or erosive reflux oesophagitis is well established. The aim of the current nationwide, multicentre ...
Implementing subcutaneous opioid options in the emergency department significantly reduced reliance on intravenous administration.
(RTTNews) - Theratechnologies Inc. (THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, has received FDA approval for the intravenous push mode ...
In this segment, Ms. Popolo discusses the practical and logistical differences between intravenous and subcutaneous immunotherapy in the treatment of advanced melanoma. She outlin ...